Daniel Buchalter, MD
Adult Reconstructive Orthopaedic Surgery · New York, NYNPI 1306379144
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Globus Medical at 39.9% of the total.
Across 126 payments — averaging $357.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$18K
- Smith+Nephew$15K
- Medical Device Business Services, Inc.$5K
- Stryker$3K
- Johnson & Johnson$2K
- Zimmer Biomet$683
- plus $1K from 11 others
What the payments were for
- Consulting fees$20,26545%
- Grants$5,83313%
- Travel & lodging$6,27714%
- Food & beverage$6,78415%
- Education$5,83313%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 11 | $17,970 |
| Smith+Nephew | 14 | $14,846 |
| Medical Device Business Services, Inc. | 13 | $5,498 |
| Stryker | 49 | $2,914 |
| Johnson & Johnson(2 entities) | 17 | $1,894 |
| Zimmer Biomet | 6 | $683 |
| Ortho Development Corporation | 3 | $286 |
| Davol Inc. | 1 | $160 |
| Orthalign Inc | 1 | $140 |
| DJO, LLC | 1 | $125 |
| Arthrex | 1 | $121 |
| Heraeus Medical, LLC. | 1 | $111 |
| Providence Medical Technology, Inc. | 3 | $81 |
| Linvatec Corporation | 1 | $57 |
| Linkbio Corp | 1 | $52 |
| Pacira Pharmaceuticals Incorporated | 2 | $41 |
| Gotham Surgical Solutions & Devices, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$3,786
- Excelsius - GPS$3,125
- Legion Revision$2,597
- OR3O Dual Mobility$1,553
- RI.HIP NAVIGATION$1,553
- JOURNEY$1,553
- MAKO$1,308
- ACTIS$1,280
- Legacy Stelkast Knee$1,181
- POLARCUP$1,045
- REDAPT$1,045
- Velys$794
- ATTUNE$533
- REAL INTELLIGENCE$280
- CMF$249
- Avenir$185
- TRIATHLON$161
- mymobility Platform$145
- Legion$144
- AETOS Shoulder System$144
How this compares
$44,993 in reported general payments places this provider in the 70th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.
See all adult reconstructive orthopaedic surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 143 | $676 |
| Pantoprazole Sodium | 41 | $321 |
| Ondansetron OdtOndansetron | 43 | $300 |
| Oxycodone Hcl | 40 | $231 |
| Mupirocin | 31 | $212 |
| Cefadroxil | 25 | $160 |
| Tramadol Hcl | 38 | $123 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in New York
- Seth JerabekNew York$7.1M
- Jose RodriguezNew York$3.4M
- Friedrich BoettnerNew York$2.9M
- Jonathan VigdorchikNew York$2.3M
- William LongNew York$1.5M
- Peter SculcoNew York$1.5M
- Roshan ShahNew York$1.3M
- Herbert CooperNew York$1.3M
- Matthew AustinNew York$986K
- Patrick MeereNew York$191K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.